OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy
Yusuke Kurita, Noritoshi Kobayashi, Motohiko Tokuhisa, et al.
Pancreatology (2018) Vol. 19, Iss. 1, pp. 127-135
Closed Access | Times Cited: 82
Yusuke Kurita, Noritoshi Kobayashi, Motohiko Tokuhisa, et al.
Pancreatology (2018) Vol. 19, Iss. 1, pp. 127-135
Closed Access | Times Cited: 82
Showing 26-50 of 82 citing articles:
Sarcopenia
Hiroyuki Asama, Makoto Ueno, Satoshi Kobayashi, et al.
Pancreas (2022) Vol. 51, Iss. 2, pp. 148-152
Closed Access | Times Cited: 16
Hiroyuki Asama, Makoto Ueno, Satoshi Kobayashi, et al.
Pancreas (2022) Vol. 51, Iss. 2, pp. 148-152
Closed Access | Times Cited: 16
Sarcopenia in pancreatic cancer: Effect on patient outcomes
Moon Hyung Choi, Seung Bae Yoon
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 12, pp. 2302-2312
Open Access | Times Cited: 16
Moon Hyung Choi, Seung Bae Yoon
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 12, pp. 2302-2312
Open Access | Times Cited: 16
Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
Yukari Suzuki, Kei Saito, Yousuke Nakai, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 3
Open Access | Times Cited: 10
Yukari Suzuki, Kei Saito, Yousuke Nakai, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 3
Open Access | Times Cited: 10
Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy
Masahiro Aichi, Sho Hasegawa, Yusuke Kurita, et al.
Nutrition (2023) Vol. 109, pp. 111966-111966
Open Access | Times Cited: 9
Masahiro Aichi, Sho Hasegawa, Yusuke Kurita, et al.
Nutrition (2023) Vol. 109, pp. 111966-111966
Open Access | Times Cited: 9
Influence of sarcopenia on postoperative complications and long-term survival in pancreatic cancer patients undergone pancreaticoduodenectomy
Guangzhen Qu, Chuanguo Zhou, Yong Zhang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 3
Guangzhen Qu, Chuanguo Zhou, Yong Zhang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 3
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study
Debora Basile, Michele Bartoletti, Maurizio Polano, et al.
Clinical Nutrition (2020) Vol. 40, Iss. 1, pp. 286-294
Closed Access | Times Cited: 27
Debora Basile, Michele Bartoletti, Maurizio Polano, et al.
Clinical Nutrition (2020) Vol. 40, Iss. 1, pp. 286-294
Closed Access | Times Cited: 27
Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: a retrospective study
Teruhisa Sakamoto, Takuki Yagyu, Ei Uchinaka, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Teruhisa Sakamoto, Takuki Yagyu, Ei Uchinaka, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy
Tomoya Emori, Masahiro Itonaga, Reiko Ashida, et al.
Pancreatology (2021) Vol. 22, Iss. 2, pp. 277-285
Closed Access | Times Cited: 23
Tomoya Emori, Masahiro Itonaga, Reiko Ashida, et al.
Pancreatology (2021) Vol. 22, Iss. 2, pp. 277-285
Closed Access | Times Cited: 23
Computed Tomography–Based Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis
Maria Del Grande, Stefania Rizzo, Gabriele Maria Nicolino, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Maria Del Grande, Stefania Rizzo, Gabriele Maria Nicolino, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
Élise Deluche, Denis Lachâtre, Mario Di Palma, et al.
The Breast (2021) Vol. 61, pp. 84-90
Open Access | Times Cited: 19
Élise Deluche, Denis Lachâtre, Mario Di Palma, et al.
The Breast (2021) Vol. 61, pp. 84-90
Open Access | Times Cited: 19
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma
Ilaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.
World Journal of Gastrointestinal Surgery (2021) Vol. 13, Iss. 9, pp. 885-903
Open Access | Times Cited: 18
Ilaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.
World Journal of Gastrointestinal Surgery (2021) Vol. 13, Iss. 9, pp. 885-903
Open Access | Times Cited: 18
Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial
Kea Turner, Dae Won Kim, Brian D. Gonzalez, et al.
Contemporary Clinical Trials Communications (2024) Vol. 38, pp. 101271-101271
Open Access | Times Cited: 2
Kea Turner, Dae Won Kim, Brian D. Gonzalez, et al.
Contemporary Clinical Trials Communications (2024) Vol. 38, pp. 101271-101271
Open Access | Times Cited: 2
Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model
Hiroki Sato, Takuma Goto, Akihiro Hayashi, et al.
Pancreatology (2021) Vol. 21, Iss. 5, pp. 892-902
Closed Access | Times Cited: 16
Hiroki Sato, Takuma Goto, Akihiro Hayashi, et al.
Pancreatology (2021) Vol. 21, Iss. 5, pp. 892-902
Closed Access | Times Cited: 16
Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients
Raoul Wochner, Dorothea Clauss, Johanna Nattenmüller, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0242785-e0242785
Open Access | Times Cited: 17
Raoul Wochner, Dorothea Clauss, Johanna Nattenmüller, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0242785-e0242785
Open Access | Times Cited: 17
An exploratory study of body composition as a predictor of dose-limiting toxicity in metastatic pancreatic cancer treated with gemcitabine plus nab-paclitaxel
Susie Youn, Angela Chen, Vincent Ha, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 8, pp. 4888-4892
Closed Access | Times Cited: 15
Susie Youn, Angela Chen, Vincent Ha, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 8, pp. 4888-4892
Closed Access | Times Cited: 15
Protein intake after the initiation of chemotherapy is an independent prognostic factor for overall survival in patients with unresectable pancreatic cancer: A prospective cohort study
Yoko Hasegawa, Hideaki Ijichi, Kei Saito, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 7, pp. 4792-4798
Closed Access | Times Cited: 13
Yoko Hasegawa, Hideaki Ijichi, Kei Saito, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 7, pp. 4792-4798
Closed Access | Times Cited: 13
Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy
Won Kyung Cho, Jeong Il Yu, Hee Chul Park, et al.
Tumori Journal (2020) Vol. 107, Iss. 3, pp. 247-253
Closed Access | Times Cited: 13
Won Kyung Cho, Jeong Il Yu, Hee Chul Park, et al.
Tumori Journal (2020) Vol. 107, Iss. 3, pp. 247-253
Closed Access | Times Cited: 13
The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer
Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, et al.
Japanese Journal of Clinical Oncology (2020) Vol. 51, Iss. 4, pp. 604-611
Open Access | Times Cited: 13
Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, et al.
Japanese Journal of Clinical Oncology (2020) Vol. 51, Iss. 4, pp. 604-611
Open Access | Times Cited: 13
A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic Cancer
Nicolas Williet, Marion Fovet, Khawla Maoui, et al.
Pancreas (2021) Vol. 50, Iss. 4, pp. 579-586
Closed Access | Times Cited: 12
Nicolas Williet, Marion Fovet, Khawla Maoui, et al.
Pancreas (2021) Vol. 50, Iss. 4, pp. 579-586
Closed Access | Times Cited: 12
Cancer cachexia and treatment toxicity
Shilpa Mukunda Chowdhry, Varun Kumar Chowdhry
Current Opinion in Supportive and Palliative Care (2019) Vol. 13, Iss. 4, pp. 292-297
Closed Access | Times Cited: 13
Shilpa Mukunda Chowdhry, Varun Kumar Chowdhry
Current Opinion in Supportive and Palliative Care (2019) Vol. 13, Iss. 4, pp. 292-297
Closed Access | Times Cited: 13
Sarcopenia in cancer—a focus on elderly cancer patients
Maximilian Marhold, Thaïs Topakian, Matthias Unseld
memo - Magazine of European Medical Oncology (2020) Vol. 14, Iss. 1, pp. 20-23
Open Access | Times Cited: 12
Maximilian Marhold, Thaïs Topakian, Matthias Unseld
memo - Magazine of European Medical Oncology (2020) Vol. 14, Iss. 1, pp. 20-23
Open Access | Times Cited: 12
The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction
Dean G. Campelj, Cara A. Timpani, Aaron C. Petersen, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3810-3810
Open Access | Times Cited: 12
Dean G. Campelj, Cara A. Timpani, Aaron C. Petersen, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3810-3810
Open Access | Times Cited: 12
An in-depth analysis on the effects of body composition in patients receiving neoadjuvant chemotherapy for urothelial cell carcinoma
Landan MacDonald, Ricardo Rendon, Myuran Thana, et al.
Canadian Urological Association Journal (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 1
Landan MacDonald, Ricardo Rendon, Myuran Thana, et al.
Canadian Urological Association Journal (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 1
Prognostic Significance of Sarcopenia and Eicosapentaenoic Acid (EPA) Levels in Patients With Unresectable Pancreatic or Biliary Tract Cancer
Kyohei Abe, Kenei Furukawa, Yoshihiro Shirai, et al.
Cancer Diagnosis & Prognosis (2024) Vol. 4, Iss. 2, pp. 135-140
Open Access | Times Cited: 1
Kyohei Abe, Kenei Furukawa, Yoshihiro Shirai, et al.
Cancer Diagnosis & Prognosis (2024) Vol. 4, Iss. 2, pp. 135-140
Open Access | Times Cited: 1
Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer
Jiyoung Keum, Hee Seung Lee, Huapyong Kang, et al.
Cancer Chemotherapy and Pharmacology (2020) Vol. 85, Iss. 4, pp. 651-659
Closed Access | Times Cited: 11
Jiyoung Keum, Hee Seung Lee, Huapyong Kang, et al.
Cancer Chemotherapy and Pharmacology (2020) Vol. 85, Iss. 4, pp. 651-659
Closed Access | Times Cited: 11
